nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—Haemoglobin decreased—Sunitinib—pancreatic cancer	0.0274	0.0359	CcSEcCtD
Levosimendan—Myocardial ischaemia—Tamoxifen—pancreatic cancer	0.0274	0.0359	CcSEcCtD
Levosimendan—Myocardial ischaemia—Sunitinib—pancreatic cancer	0.0234	0.0307	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—PDX1—pancreatic cancer	0.0217	0.0915	CbGpPWpGaD
Levosimendan—Myocardial ischaemia—Irinotecan—pancreatic cancer	0.0193	0.0253	CcSEcCtD
Levosimendan—Myocardial ischaemia—Fluorouracil—pancreatic cancer	0.0185	0.0242	CcSEcCtD
Levosimendan—Haemoglobin decreased—Docetaxel—pancreatic cancer	0.0156	0.0204	CcSEcCtD
Levosimendan—Hypokalaemia—Erlotinib—pancreatic cancer	0.0144	0.0189	CcSEcCtD
Levosimendan—Cardiac failure—Sunitinib—pancreatic cancer	0.014	0.0184	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—SLC2A2—pancreatic cancer	0.0137	0.0577	CbGpPWpGaD
Levosimendan—Myocardial ischaemia—Docetaxel—pancreatic cancer	0.0134	0.0175	CcSEcCtD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.0125	0.0526	CbGpPWpGaD
Levosimendan—Hypokalaemia—Sunitinib—pancreatic cancer	0.0125	0.0163	CcSEcCtD
Levosimendan—Cardiac failure—Gemcitabine—pancreatic cancer	0.0112	0.0147	CcSEcCtD
Levosimendan—Cardiac failure—Fluorouracil—pancreatic cancer	0.0111	0.0145	CcSEcCtD
Levosimendan—Hypokalaemia—Irinotecan—pancreatic cancer	0.0103	0.0134	CcSEcCtD
Levosimendan—Hypokalaemia—Gemcitabine—pancreatic cancer	0.00999	0.0131	CcSEcCtD
Levosimendan—Mental disorder—Erlotinib—pancreatic cancer	0.00958	0.0126	CcSEcCtD
Levosimendan—Malnutrition—Erlotinib—pancreatic cancer	0.00952	0.0125	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00916	0.0387	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00882	0.0372	CbGpPWpGaD
Levosimendan—Cardiac disorder—Sunitinib—pancreatic cancer	0.00878	0.0115	CcSEcCtD
Levosimendan—Angiopathy—Sunitinib—pancreatic cancer	0.00859	0.0113	CcSEcCtD
Levosimendan—Mental disorder—Sunitinib—pancreatic cancer	0.00829	0.0109	CcSEcCtD
Levosimendan—Malnutrition—Sunitinib—pancreatic cancer	0.00824	0.0108	CcSEcCtD
Levosimendan—Atrial fibrillation—Docetaxel—pancreatic cancer	0.00822	0.0108	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Epirubicin—pancreatic cancer	0.00801	0.0105	CcSEcCtD
Levosimendan—Cardiac failure—Docetaxel—pancreatic cancer	0.00798	0.0105	CcSEcCtD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.00786	0.0331	CbGpPWpGaD
Levosimendan—Nervous system disorder—Erlotinib—pancreatic cancer	0.00762	0.00998	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Doxorubicin—pancreatic cancer	0.00742	0.00972	CcSEcCtD
Levosimendan—PDE3A—Platelet homeostasis—PPP2R5B—pancreatic cancer	0.00724	0.0306	CbGpPWpGaD
Levosimendan—Ventricular tachycardia—Epirubicin—pancreatic cancer	0.00724	0.00949	CcSEcCtD
Levosimendan—Cardiac disorder—Irinotecan—pancreatic cancer	0.00724	0.00948	CcSEcCtD
Levosimendan—Insomnia—Tamoxifen—pancreatic cancer	0.0071	0.00931	CcSEcCtD
Levosimendan—Angiopathy—Irinotecan—pancreatic cancer	0.00707	0.00927	CcSEcCtD
Levosimendan—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00705	0.00924	CcSEcCtD
Levosimendan—Insomnia—Erlotinib—pancreatic cancer	0.00703	0.00921	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00694	0.0293	CbGpPWpGaD
Levosimendan—Angiopathy—Gemcitabine—pancreatic cancer	0.00689	0.00903	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00678	0.00888	CcSEcCtD
Levosimendan—Constipation—Tamoxifen—pancreatic cancer	0.00671	0.0088	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00671	0.00879	CcSEcCtD
Levosimendan—Ventricular tachycardia—Doxorubicin—pancreatic cancer	0.0067	0.00878	CcSEcCtD
Levosimendan—Constipation—Erlotinib—pancreatic cancer	0.00664	0.00871	CcSEcCtD
Levosimendan—Nervous system disorder—Sunitinib—pancreatic cancer	0.00659	0.00864	CcSEcCtD
Levosimendan—Insomnia—Sunitinib—pancreatic cancer	0.00608	0.00797	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00581	0.00761	CcSEcCtD
Levosimendan—Constipation—Sunitinib—pancreatic cancer	0.00575	0.00754	CcSEcCtD
Levosimendan—Nervous system disorder—Irinotecan—pancreatic cancer	0.00543	0.00712	CcSEcCtD
Levosimendan—Cardiac failure—Epirubicin—pancreatic cancer	0.00538	0.00706	CcSEcCtD
Levosimendan—KCNJ11—Regulation of insulin secretion—GLP1R—pancreatic cancer	0.00538	0.0227	CbGpPWpGaD
Levosimendan—Diarrhoea—Tamoxifen—pancreatic cancer	0.00537	0.00704	CcSEcCtD
Levosimendan—Diarrhoea—Erlotinib—pancreatic cancer	0.00531	0.00697	CcSEcCtD
Levosimendan—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00529	0.00694	CcSEcCtD
Levosimendan—Nervous system disorder—Fluorouracil—pancreatic cancer	0.0052	0.00682	CcSEcCtD
Levosimendan—Dizziness—Tamoxifen—pancreatic cancer	0.00519	0.0068	CcSEcCtD
Levosimendan—Tachycardia—Fluorouracil—pancreatic cancer	0.00518	0.00679	CcSEcCtD
Levosimendan—Hypotension—Irinotecan—pancreatic cancer	0.00518	0.00678	CcSEcCtD
Levosimendan—Dizziness—Erlotinib—pancreatic cancer	0.00514	0.00673	CcSEcCtD
Levosimendan—Hypotension—Gemcitabine—pancreatic cancer	0.00504	0.00661	CcSEcCtD
Levosimendan—KCNJ11—Regulation of insulin secretion—SLC2A2—pancreatic cancer	0.00502	0.0212	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.00502	0.0212	CbGpPWpGaD
Levosimendan—Insomnia—Irinotecan—pancreatic cancer	0.00501	0.00657	CcSEcCtD
Levosimendan—Cardiac disorder—Docetaxel—pancreatic cancer	0.005	0.00656	CcSEcCtD
Levosimendan—Vomiting—Tamoxifen—pancreatic cancer	0.00499	0.00654	CcSEcCtD
Levosimendan—Cardiac failure—Doxorubicin—pancreatic cancer	0.00498	0.00653	CcSEcCtD
Levosimendan—Hypotension—Fluorouracil—pancreatic cancer	0.00496	0.0065	CcSEcCtD
Levosimendan—Vomiting—Erlotinib—pancreatic cancer	0.00494	0.00647	CcSEcCtD
Levosimendan—Headache—Tamoxifen—pancreatic cancer	0.00492	0.00645	CcSEcCtD
Levosimendan—Angiopathy—Docetaxel—pancreatic cancer	0.00489	0.00641	CcSEcCtD
Levosimendan—Insomnia—Gemcitabine—pancreatic cancer	0.00488	0.0064	CcSEcCtD
Levosimendan—Headache—Erlotinib—pancreatic cancer	0.00487	0.00638	CcSEcCtD
Levosimendan—Insomnia—Fluorouracil—pancreatic cancer	0.0048	0.00629	CcSEcCtD
Levosimendan—Hypokalaemia—Epirubicin—pancreatic cancer	0.00478	0.00627	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00478	0.00627	CcSEcCtD
Levosimendan—Constipation—Irinotecan—pancreatic cancer	0.00474	0.00621	CcSEcCtD
Levosimendan—Mental disorder—Docetaxel—pancreatic cancer	0.00472	0.00619	CcSEcCtD
Levosimendan—Malnutrition—Docetaxel—pancreatic cancer	0.00469	0.00615	CcSEcCtD
Levosimendan—Nausea—Tamoxifen—pancreatic cancer	0.00466	0.00611	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00466	0.00611	CcSEcCtD
Levosimendan—Constipation—Gemcitabine—pancreatic cancer	0.00461	0.00605	CcSEcCtD
Levosimendan—Nausea—Erlotinib—pancreatic cancer	0.00461	0.00605	CcSEcCtD
Levosimendan—Diarrhoea—Sunitinib—pancreatic cancer	0.0046	0.00603	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00458	0.006	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—SCT—pancreatic cancer	0.00446	0.0188	CbGpPWpGaD
Levosimendan—Dizziness—Sunitinib—pancreatic cancer	0.00445	0.00583	CcSEcCtD
Levosimendan—Hypokalaemia—Doxorubicin—pancreatic cancer	0.00442	0.0058	CcSEcCtD
Levosimendan—Vomiting—Sunitinib—pancreatic cancer	0.00428	0.0056	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—GLP1R—pancreatic cancer	0.00423	0.0178	CbGpPWpGaD
Levosimendan—Headache—Sunitinib—pancreatic cancer	0.00421	0.00552	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—GLP1R—pancreatic cancer	0.00414	0.0175	CbGpPWpGaD
Levosimendan—Nausea—Sunitinib—pancreatic cancer	0.00399	0.00523	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—SLC2A2—pancreatic cancer	0.00395	0.0167	CbGpPWpGaD
Levosimendan—Diarrhoea—Irinotecan—pancreatic cancer	0.00379	0.00497	CcSEcCtD
Levosimendan—Nervous system disorder—Docetaxel—pancreatic cancer	0.00375	0.00492	CcSEcCtD
Levosimendan—Tachycardia—Docetaxel—pancreatic cancer	0.00374	0.0049	CcSEcCtD
Levosimendan—KCNJ11—Regulation of insulin secretion—GCG—pancreatic cancer	0.00373	0.0157	CbGpPWpGaD
Levosimendan—Diarrhoea—Gemcitabine—pancreatic cancer	0.00369	0.00484	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—IAPP—pancreatic cancer	0.00367	0.0155	CbGpPWpGaD
Levosimendan—Dizziness—Irinotecan—pancreatic cancer	0.00366	0.0048	CcSEcCtD
Levosimendan—Diarrhoea—Fluorouracil—pancreatic cancer	0.00363	0.00476	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.0036	0.0152	CbGpPWpGaD
Levosimendan—Hypotension—Docetaxel—pancreatic cancer	0.00358	0.00469	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—PTHLH—pancreatic cancer	0.00352	0.0149	CbGpPWpGaD
Levosimendan—Vomiting—Irinotecan—pancreatic cancer	0.00352	0.00462	CcSEcCtD
Levosimendan—Dizziness—Fluorouracil—pancreatic cancer	0.00351	0.0046	CcSEcCtD
Levosimendan—Headache—Irinotecan—pancreatic cancer	0.00347	0.00455	CcSEcCtD
Levosimendan—Insomnia—Docetaxel—pancreatic cancer	0.00346	0.00454	CcSEcCtD
Levosimendan—Vomiting—Gemcitabine—pancreatic cancer	0.00343	0.0045	CcSEcCtD
Levosimendan—Headache—Gemcitabine—pancreatic cancer	0.00338	0.00443	CcSEcCtD
Levosimendan—Cardiac disorder—Epirubicin—pancreatic cancer	0.00337	0.00442	CcSEcCtD
Levosimendan—Vomiting—Fluorouracil—pancreatic cancer	0.00337	0.00442	CcSEcCtD
Levosimendan—Headache—Fluorouracil—pancreatic cancer	0.00332	0.00436	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00331	0.00433	CcSEcCtD
Levosimendan—Angiopathy—Epirubicin—pancreatic cancer	0.0033	0.00432	CcSEcCtD
Levosimendan—Nausea—Irinotecan—pancreatic cancer	0.00329	0.00431	CcSEcCtD
Levosimendan—Constipation—Docetaxel—pancreatic cancer	0.00327	0.00429	CcSEcCtD
Levosimendan—Nausea—Gemcitabine—pancreatic cancer	0.0032	0.0042	CcSEcCtD
Levosimendan—Mental disorder—Epirubicin—pancreatic cancer	0.00318	0.00417	CcSEcCtD
Levosimendan—Malnutrition—Epirubicin—pancreatic cancer	0.00316	0.00415	CcSEcCtD
Levosimendan—Nausea—Fluorouracil—pancreatic cancer	0.00315	0.00413	CcSEcCtD
Levosimendan—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00312	0.00409	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—TNF—pancreatic cancer	0.00309	0.013	CbGpPWpGaD
Levosimendan—Angiopathy—Doxorubicin—pancreatic cancer	0.00305	0.004	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.00302	0.0127	CbGpPWpGaD
Levosimendan—Mental disorder—Doxorubicin—pancreatic cancer	0.00295	0.00386	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—GCG—pancreatic cancer	0.00293	0.0124	CbGpPWpGaD
Levosimendan—Malnutrition—Doxorubicin—pancreatic cancer	0.00293	0.00384	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—GCG—pancreatic cancer	0.00287	0.0121	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—STK11—pancreatic cancer	0.00276	0.0116	CbGpPWpGaD
Levosimendan—Diarrhoea—Docetaxel—pancreatic cancer	0.00262	0.00343	CcSEcCtD
Levosimendan—Nervous system disorder—Epirubicin—pancreatic cancer	0.00253	0.00332	CcSEcCtD
Levosimendan—Dizziness—Docetaxel—pancreatic cancer	0.00253	0.00332	CcSEcCtD
Levosimendan—Tachycardia—Epirubicin—pancreatic cancer	0.00252	0.0033	CcSEcCtD
Levosimendan—Vomiting—Docetaxel—pancreatic cancer	0.00243	0.00319	CcSEcCtD
Levosimendan—Hypotension—Epirubicin—pancreatic cancer	0.00241	0.00316	CcSEcCtD
Levosimendan—Headache—Docetaxel—pancreatic cancer	0.0024	0.00314	CcSEcCtD
Levosimendan—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00234	0.00307	CcSEcCtD
Levosimendan—Insomnia—Epirubicin—pancreatic cancer	0.00234	0.00306	CcSEcCtD
Levosimendan—Tachycardia—Doxorubicin—pancreatic cancer	0.00233	0.00306	CcSEcCtD
Levosimendan—Nausea—Docetaxel—pancreatic cancer	0.00227	0.00298	CcSEcCtD
Levosimendan—Hypotension—Doxorubicin—pancreatic cancer	0.00223	0.00293	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00223	0.00292	CcSEcCtD
Levosimendan—Constipation—Epirubicin—pancreatic cancer	0.00221	0.00289	CcSEcCtD
Levosimendan—Insomnia—Doxorubicin—pancreatic cancer	0.00216	0.00283	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00206	0.0027	CcSEcCtD
Levosimendan—Constipation—Doxorubicin—pancreatic cancer	0.00204	0.00268	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.00196	0.00825	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.00187	0.0079	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.0018	0.00761	CbGpPWpGaD
Levosimendan—Diarrhoea—Epirubicin—pancreatic cancer	0.00177	0.00232	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—IFNA5—pancreatic cancer	0.00172	0.00725	CbGpPWpGaD
Levosimendan—Dizziness—Epirubicin—pancreatic cancer	0.00171	0.00224	CcSEcCtD
Levosimendan—Vomiting—Epirubicin—pancreatic cancer	0.00164	0.00215	CcSEcCtD
Levosimendan—Diarrhoea—Doxorubicin—pancreatic cancer	0.00163	0.00214	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—PPP2R5B—pancreatic cancer	0.00162	0.00685	CbGpPWpGaD
Levosimendan—Headache—Epirubicin—pancreatic cancer	0.00162	0.00212	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.00159	0.0067	CbGpPWpGaD
Levosimendan—Dizziness—Doxorubicin—pancreatic cancer	0.00158	0.00207	CcSEcCtD
Levosimendan—Nausea—Epirubicin—pancreatic cancer	0.00153	0.00201	CcSEcCtD
Levosimendan—Vomiting—Doxorubicin—pancreatic cancer	0.00152	0.00199	CcSEcCtD
Levosimendan—Headache—Doxorubicin—pancreatic cancer	0.0015	0.00196	CcSEcCtD
Levosimendan—Nausea—Doxorubicin—pancreatic cancer	0.00142	0.00186	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.00136	0.00574	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRLHR—pancreatic cancer	0.00134	0.00567	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.00132	0.00557	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—SSTR3—pancreatic cancer	0.00126	0.00531	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GDI1—pancreatic cancer	0.00123	0.0052	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GDI2—pancreatic cancer	0.00123	0.0052	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00121	0.00509	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PPY—pancreatic cancer	0.00118	0.00499	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00116	0.0049	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SSTR3—pancreatic cancer	0.00114	0.00482	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00112	0.00473	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SSTR1—pancreatic cancer	0.0011	0.00462	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PPY—pancreatic cancer	0.00107	0.00453	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SSTR2—pancreatic cancer	0.00105	0.00445	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCKBR—pancreatic cancer	0.00102	0.0043	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CD44—pancreatic cancer	0.000972	0.0041	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GAST—pancreatic cancer	0.000964	0.00407	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IFNA1—pancreatic cancer	0.000942	0.00397	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—SCT—pancreatic cancer	0.000914	0.00386	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IFNA2—pancreatic cancer	0.000876	0.0037	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GAST—pancreatic cancer	0.000876	0.00369	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCK—pancreatic cancer	0.000872	0.00368	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CNR2—pancreatic cancer	0.00085	0.00359	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00085	0.00359	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000836	0.00353	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SCT—pancreatic cancer	0.00083	0.0035	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRLHR—pancreatic cancer	0.000794	0.00335	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCK—pancreatic cancer	0.000792	0.00334	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PRSS1—pancreatic cancer	0.000792	0.00334	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CNR2—pancreatic cancer	0.000772	0.00326	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GLP1R—pancreatic cancer	0.000772	0.00326	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCKAR—pancreatic cancer	0.000759	0.0032	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IAPP—pancreatic cancer	0.000753	0.00318	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ACVR1B—pancreatic cancer	0.000746	0.00315	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ZNRF3—pancreatic cancer	0.000746	0.00315	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000723	0.00305	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—HRAS—pancreatic cancer	0.000721	0.00304	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SHH—pancreatic cancer	0.000692	0.00292	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ARG2—pancreatic cancer	0.000686	0.0029	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IAPP—pancreatic cancer	0.000684	0.00288	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SSTR3—pancreatic cancer	0.000675	0.00285	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DTX1—pancreatic cancer	0.000675	0.00285	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—SST—pancreatic cancer	0.000661	0.00279	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTHLH—pancreatic cancer	0.000656	0.00277	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTCH1—pancreatic cancer	0.000656	0.00277	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SSTR1—pancreatic cancer	0.000647	0.00273	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPY—pancreatic cancer	0.000635	0.00268	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SSTR2—pancreatic cancer	0.000623	0.00263	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAU—pancreatic cancer	0.000622	0.00262	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CNR1—pancreatic cancer	0.00061	0.00257	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCKBR—pancreatic cancer	0.000602	0.00254	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SST—pancreatic cancer	0.0006	0.00253	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TYMP—pancreatic cancer	0.0006	0.00253	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GCG—pancreatic cancer	0.000589	0.00248	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DTX4—pancreatic cancer	0.000566	0.00239	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GLI1—pancreatic cancer	0.000566	0.00239	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000562	0.00237	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CNR1—pancreatic cancer	0.000554	0.00234	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CG—pancreatic cancer	0.000553	0.00233	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NRP1—pancreatic cancer	0.00055	0.00232	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00055	0.00232	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EGF—pancreatic cancer	0.000547	0.00231	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GCG—pancreatic cancer	0.000535	0.00226	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HEY2—pancreatic cancer	0.00053	0.00223	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GAST—pancreatic cancer	0.000517	0.00218	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AGTR1—pancreatic cancer	0.00051	0.00215	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SCT—pancreatic cancer	0.00049	0.00207	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HEY1—pancreatic cancer	0.00049	0.00207	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CD—pancreatic cancer	0.000486	0.00205	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GLP1R—pancreatic cancer	0.000484	0.00204	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—DPYD—pancreatic cancer	0.000476	0.00201	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCK—pancreatic cancer	0.000468	0.00197	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CNR2—pancreatic cancer	0.000456	0.00192	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GLP1R—pancreatic cancer	0.000456	0.00192	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC2A2—pancreatic cancer	0.000451	0.0019	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCKAR—pancreatic cancer	0.000449	0.00189	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAG2—pancreatic cancer	0.000435	0.00183	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MEN1—pancreatic cancer	0.000429	0.00181	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CB—pancreatic cancer	0.000424	0.00179	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SHH—pancreatic cancer	0.000409	0.00172	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000406	0.00171	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IAPP—pancreatic cancer	0.000404	0.0017	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTHLH—pancreatic cancer	0.000388	0.00164	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTCH1—pancreatic cancer	0.000388	0.00164	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SST—pancreatic cancer	0.000355	0.0015	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.00035	0.00148	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CD44—pancreatic cancer	0.00035	0.00147	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAG1—pancreatic cancer	0.000347	0.00146	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000346	0.00146	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—HRAS—pancreatic cancer	0.000341	0.00144	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SRC—pancreatic cancer	0.00034	0.00143	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCG—pancreatic cancer	0.000335	0.00141	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—pancreatic cancer	0.000331	0.0014	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CNR1—pancreatic cancer	0.000327	0.00138	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NRAS—pancreatic cancer	0.000327	0.00138	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000318	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GCG—pancreatic cancer	0.000316	0.00133	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—STK11—pancreatic cancer	0.000315	0.00133	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000307	0.0013	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB1—pancreatic cancer	0.000304	0.00128	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGTR1—pancreatic cancer	0.000301	0.00127	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STK11—pancreatic cancer	0.000297	0.00125	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KRAS—pancreatic cancer	0.000281	0.00119	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000279	0.00118	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TYMS—pancreatic cancer	0.000271	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000268	0.00113	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SMAD4—pancreatic cancer	0.00026	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—pancreatic cancer	0.000258	0.00109	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000257	0.00109	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HES1—pancreatic cancer	0.000254	0.00107	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—pancreatic cancer	0.00025	0.00105	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000243	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HRAS—pancreatic cancer	0.000239	0.00101	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000234	0.000986	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TERT—pancreatic cancer	0.000223	0.000939	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOE—pancreatic cancer	0.00022	0.00093	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIF1A—pancreatic cancer	0.000213	0.000898	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TSC2—pancreatic cancer	0.000212	0.000896	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—pancreatic cancer	0.000211	0.000891	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOE—pancreatic cancer	0.000208	0.000877	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KDR—pancreatic cancer	0.000204	0.000859	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CG—pancreatic cancer	0.000199	0.000839	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000194	0.000817	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARG—pancreatic cancer	0.000192	0.00081	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000192	0.000809	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000188	0.000791	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—NRAS—pancreatic cancer	0.000188	0.000791	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGF—pancreatic cancer	0.000185	0.000782	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CD—pancreatic cancer	0.000175	0.000738	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—pancreatic cancer	0.000171	0.000721	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000165	0.000696	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000163	0.000689	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KRAS—pancreatic cancer	0.000161	0.000681	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CB—pancreatic cancer	0.000152	0.000643	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—pancreatic cancer	0.000151	0.000637	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000148	0.000626	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000144	0.000606	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL8—pancreatic cancer	0.000138	0.000583	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HRAS—pancreatic cancer	0.000137	0.000579	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—pancreatic cancer	0.000133	0.000563	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—pancreatic cancer	0.000132	0.000558	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTEN—pancreatic cancer	0.000132	0.000556	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCND1—pancreatic cancer	0.000129	0.000543	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CTNNB1—pancreatic cancer	0.000127	0.000538	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—pancreatic cancer	0.000125	0.000527	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTEN—pancreatic cancer	0.000124	0.000524	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—pancreatic cancer	0.000121	0.000511	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SRC—pancreatic cancer	0.000115	0.000486	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—pancreatic cancer	0.000112	0.000473	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT3—pancreatic cancer	0.000111	0.000469	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NRAS—pancreatic cancer	0.000111	0.000467	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—pancreatic cancer	0.000103	0.000435	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFB1—pancreatic cancer	0.000103	0.000434	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—pancreatic cancer	0.000101	0.000426	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KRAS—pancreatic cancer	9.54e-05	0.000402	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—pancreatic cancer	9.29e-05	0.000392	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—pancreatic cancer	8.76e-05	0.00037	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—pancreatic cancer	8.48e-05	0.000358	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HRAS—pancreatic cancer	8.11e-05	0.000342	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—pancreatic cancer	7.59e-05	0.00032	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—pancreatic cancer	7.16e-05	0.000302	CbGpPWpGaD
